Am­gen’s leg­endary lawyer corps los­es a ma­jor court fight at­tempt­ing to quash PC­SK9 ri­val from Sanofi, Re­gen­eron

Sanofi and Re­gen­eron may be los­ing the bat­tle for sales of their PC­SK9 drug Pralu­ent in their fight against Am­gen’s Repatha for mar­ket share — but they just won a bad­ly need­ed vic­to­ry on the le­gal front.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.